Size‐exclusion LC‐UV/HRMS based method for the analysis of aggregates in synthetic GLP‐1 analog liraglutide and evaluation of excipient impact on aggregation
Biomedical Chromatography · 2024
DOI: 10.1002/bmc.5983 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Devendra Badgujar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research-Ahmedabad (Ministry of Chemicals and Fertilizers, …. Hauptthemen laut MEDLINE: Liraglutide, Chromatography, Gel, Excipients, Mass Spectrometry. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India.
Abstract (Originalsprache)
Peptide aggregation is one of the key challenges associated with the development of therapeutic peptides. Peptide and protein aggregates are considered as one of the most important critical quality attributes (CQA). Therapeutic liraglutide (LGT) is proteinaceous in nature, and aggregation can be triggered by various environmental stress condition. Therefore, it is essential to separate and identify aggregation states of such drugs. In this study, we have established size exclusion chromatography‐liquid chromatography‐ultraviolet/high resolution mass spectrometry (SEC‐LC‐UV/HRMS) method to separate and identify the stress induced LGT aggregates. LGT samples were subjected to photolytic, thermal, freeze thaw and shaking stress conditions. Additionally, LGT solution was incubated with surfactant and excipient that are commonly used in peptide formulation, to evaluate their impact on aggregation level and physicochemical stability over time. The developed SEC method was also validated for specificity, accuracy, precision and linearity. The results of this study will be useful for investigators to monitor LGT aggregates during product development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research-Ahmedabad (Ministry of Chemicals and Fertilizers, Government of India), Opposite Air Force Station, Palaj, India.
ORCID-Profile: Nitish Sharma
Förderung
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India
Zitieren
APA
Badgujar, D., Bawake, S., Chawathe, A., & Sharma, N. (2024). Size‐exclusion LC‐UV/HRMS based method for the analysis of aggregates in synthetic GLP‐1 analog liraglutide and evaluation of excipient impact on aggregation. Biomedical Chromatography. https://doi.org/10.1002/bmc.5983
Vancouver
Badgujar D, Bawake S, Chawathe A, Sharma N. Size‐exclusion LC‐UV/HRMS based method for the analysis of aggregates in synthetic GLP‐1 analog liraglutide and evaluation of excipient impact on aggregation. Biomedical Chromatography. 2024. doi:10.1002/bmc.5983
BibTeX
@article{Badgujar2024,
author = {Badgujar, Devendra and Bawake, Sanket and Chawathe, Ashwini and Sharma, Nitish},
title = {Size‐exclusion LC‐UV/HRMS based method for the analysis of aggregates in synthetic GLP‐1 analog liraglutide and evaluation of excipient impact on aggregation},
journal = {Biomedical Chromatography},
year = {2024},
doi = {10.1002/bmc.5983}
}
EUVIMED